Startseite Medizin Renal impairment compromises the use of total homocysteine and methylmalonic acid but not total vitamin B12 and holotranscobalamin in screening for vitamin B12 deficiency in the aged
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Renal impairment compromises the use of total homocysteine and methylmalonic acid but not total vitamin B12 and holotranscobalamin in screening for vitamin B12 deficiency in the aged

  • Saila Loikas , Pertti Koskinen , Kerttu Irjala , Minna Löppönen , Raimo Isoaho , Sirkka-Liisa Kivelä und Tarja-Terttu Pelliniemi
Veröffentlicht/Copyright: 20. Februar 2007
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 45 Heft 2

Abstract

Background: Vitamin B12 deficiency and renal impairment are common in the aged, and therefore the screening test for vitamin B12 deficiency should not be affected by renal function. Renal impairment has been associated with increased concentrations of plasma total homocysteine and methylmalonic acid, as well as increased total vitamin B12 and holotranscobalamin concentrations.

Methods: The effect of renal impairment on vitamin B12-related biochemical variables was assessed in 1011 aged subjects.

Results: Renal function as indicated by serum cystatin C correlated strongly with plasma total homocysteine (rs=0.53, p<0.001) and serum methylmalonic acid (rs=0.27, p<0.001), but not with serum total vitamin B12 (rs=−0.04, p=0.227) or holotranscobalamin (rs=−0.01, p=0.817).

Conclusions: Either total vitamin B12 or holotranscobalamin rather than homocysteine or methylmalonic acid should be used when screening an aged population prone to renal impairment.

Clin Chem Lab Med 2007;45:197–201.

:

Corresponding author: S. Loikas, Department of Clinical Chemistry, Turku University Central Hospital, P.O. Box 52, 20521 Turku, Finland Fax: +358-2-2613920

References

1. Snow CF. Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician. Arch Intern Med1999;159:1289–98.10.1001/archinte.159.12.1289Suche in Google Scholar PubMed

2. Klee GG. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs. vitamin B(12) and folate. Clin Chem2000;46:1277–83.10.1093/clinchem/46.8.1277Suche in Google Scholar

3. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem2004;50:3–32.10.1373/clinchem.2003.021634Suche in Google Scholar PubMed

4. Herzlich B, Herbert V. Depletion of serum holotranscobalamin II. An early sign of negative vitamin B12 balance. Lab Invest1988;58:332–7.Suche in Google Scholar

5. Carmel R. Measuring and interpreting holo-transcobalamin (holo-transcobalamin II). Clin Chem2002;48:407–9.10.1093/clinchem/48.3.407Suche in Google Scholar

6. Nexo E, Hvas AM, Bleie O, Refsum H, Fedosov SN, Vollset SE, et al. Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study. Clin Chem2002;48:1768–71.10.1093/clinchem/48.10.1768Suche in Google Scholar

7. Lindgren A. Elevated serum methylmalonic acid. How much comes from cobalamin deficiency and how much comes from the kidneys? Scand J Clin Lab Invest2002;62:15–9.10.1080/003655102753517154Suche in Google Scholar PubMed

8. Friedman AN, Bostom AG, Selhub J, Levey AS, Rosenberg IH. The kidney and homocysteine metabolism. J Am Soc Nephrol2001;12:2181–9.10.1681/ASN.V12102181Suche in Google Scholar PubMed

9. van Guldener C, Stehouwer CD. Homocysteine metabolism in renal disease. Clin Chem Lab Med2003;41:1412–7.10.1515/CCLM.2003.217Suche in Google Scholar PubMed

10. van Guldener C, Stam F, Stehouwer CD. Hyperhomocysteinaemia in chronic kidney disease: focus on transmethylation. Clin Chem Lab Med2005;43:1026–31.10.1515/CCLM.2005.180Suche in Google Scholar PubMed

11. Herrmann W, Obeid R. Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients. Clin Chem Lab Med2005;43:1039–47.10.1515/CCLM.2005.182Suche in Google Scholar PubMed

12. Nielsen R, Sorensen BS, Birn H, Christensen EI, Nexo E. Transcellular transport of vitamin B(12) in LLC-PK1 renal proximal tubule cells. J Am Soc Nephrol2001;12:1099–106.10.1681/ASN.V1261099Suche in Google Scholar PubMed

13. Birn H, Willnow TE, Nielsen R, Norden AG, Bonsch C, Moestrup SK, et al. Megalin is essential for renal proximal tubule reabsorption and accumulation of transcobalamin-B(12). Am J Physiol Renal Physiol2002;282:F408–16.10.1152/ajprenal.00206.2000Suche in Google Scholar PubMed

14. Carmel R, Vasireddy H, Aurangzeb I, George K. High serum cobalamin levels in the clinical setting – clinical associations and holo-transcobalamin changes. Clin Lab Haematol2001;23:365–71.10.1046/j.1365-2257.2001.00134.xSuche in Google Scholar PubMed

15. Herrmann W, Obeid R, Schorr H, Geisel J. Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med2003;41:1478–88.10.1515/CCLM.2003.227Suche in Google Scholar PubMed

16. Hvas AM, Nexo E. Holotranscobalamin – a first choice assay for diagnosing early vitamin B deficiency? J Intern Med2005;257:289–98.10.1111/j.1365-2796.2004.01437.xSuche in Google Scholar PubMed

17. Miller JW, Garrod MG, Rockwood AL, Kushnir MM, Allen LH, Haan MN, et al. Measurement of total vitamin B12 and holotranscobalamin, singly and in combination, in screening for metabolic vitamin B12 deficiency. Clin Chem2006;52:278–85.10.1373/clinchem.2005.061382Suche in Google Scholar PubMed

18. The Lieto Study. http://www.utu.fi/med/yleislaak/lietostd.html. Institute of Clinical Medicine, Family Medicine, University of Turku. Accessed March 15, 2006.Suche in Google Scholar

19. Loikas S, Lopponen M, Irjala K, Isoaho R, Kivela SL, Koskinen P, et al. Vitamin B12 deficiency in the aged – a population based study. Age Ageing 2006. Accepted for publication.10.1093/ageing/afl150Suche in Google Scholar PubMed

20. Loikas S, Lopponen M, Suominen P, Moller J, Irjala K, Isoaho R, et al. RIA for serum holo-transcobalamin: method evaluation in the clinical laboratory and reference interval. Clin Chem2003;49:455–62.10.1373/49.3.455Suche in Google Scholar PubMed

21. Rasmussen K, Moller J, Lyngbak M, Pedersen AM, Dybkjaer L. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem1996;42:630–6.10.1093/clinchem/42.4.630Suche in Google Scholar

22. Obeid R, Schorr H, Eckert R, Herrmann W. Vitamin B12 status in the elderly as judged by available biochemical markers. Clin Chem2004;50:238–41.10.1373/clinchem.2003.021717Suche in Google Scholar PubMed

23. Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem2002;48:699–707.10.1093/clinchem/48.5.699Suche in Google Scholar

24. Wasen E, Suominen P, Isoaho R, Mattila K, Virtanen A, Kivela SL, et al. Serum cystatin C as a marker of kidney dysfunction in an elderly population. Clin Chem2002;48:1138–40.10.1093/clinchem/48.7.1138Suche in Google Scholar

25. Wasen E, Isoaho R, Mattila K, Vahlberg T, Kivela SL, Irjala K. Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C. J Intern Med2004;256:70–8.10.1111/j.1365-2796.2004.01340.xSuche in Google Scholar PubMed

26. Nexo E, Hansen M, Rasmussen K, Lindgren A, Grasbeck R. How to diagnose cobalamin deficiency. Scand J Clin Lab Invest Suppl1994;219:61–76.10.3109/00365519409088580Suche in Google Scholar PubMed

27. Bolann BJ, Solli JD, Schneede J, Grottum KA, Loraas A, Stokkeland M, et al. Evaluation of indicators of cobalamin deficiency defined as cobalamin-induced reduction in increased serum methylmalonic acid. Clin Chem2000;46:1744–50.10.1093/clinchem/46.11.1744Suche in Google Scholar

28. Schneede J, Ueland PM. Novel and established markers of cobalamin deficiency: complementary or exclusive diagnostic strategies. Semin Vasc Med2005;5:140–55.10.1055/s-2005-872399Suche in Google Scholar PubMed

Published Online: 2007-02-20
Published in Print: 2007-02-01

©2007 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Associations between folate, vitamin B12, homocysteine and pathologies related to aging: the need to consider complex nutrient-nutrient and gene-nutrient interactions and the functional and socio-economic determinants in population-based studies
  2. Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation
  3. Association of vitamin B12, folate and homocysteine with functional and pathological characteristics of the elderly in a mountainous village in Sicily
  4. Association of thyroid dysfunction with vitamin B12, folate and plasma homocysteine levels in the elderly: a population-based study in Sicily
  5. Desmond (Des) Kenny MSc MCB FICI FRCPath Eur Clin Chem, 1941–2006
  6. Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis
  7. Patient hydration: a major source of laboratory uncertainty
  8. Determination of the hepatitis C virus subtype: comparison of sequencing and reverse hybridization assays
  9. Quantification of relative changes in specific mRNAs from frozen whole blood – methodological considerations and clinical implications
  10. HER-2 protein concentrations in breast cancer cells increase before immunohistochemical and fluorescence in situ hybridization analysis turn positive
  11. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis
  12. Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis
  13. Retrospective study of monoclonal gammopathies detected in the clinical laboratory of a Spanish healthcare district: 14-year series
  14. Renal impairment compromises the use of total homocysteine and methylmalonic acid but not total vitamin B12 and holotranscobalamin in screening for vitamin B12 deficiency in the aged
  15. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome
  16. Amniotic fibronectin fragmentation and expression of its domains, sialyl and fucosyl glycotopes associated with pregnancy complicated by intrauterine infection
  17. Predicted influence of sample hematocrit on injected mass of internal standard in mass spectrometry assays utilizing simple protein precipitation for sample preparation
  18. Evaluation of cardiovascular risk factors and related clinical markers in healthy young Japanese adults
  19. Cardiac natriuretic peptides after myocardial infarction: relationship with infarct size, left ventricular function and remodelling assessed by 99mTc-sestamibi gated-single photon emission tomography
  20. Plasma homocysteine cutoff values for venous thrombosis
  21. Lipid transfer protein activities in subjects with impaired glucose tolerance
  22. Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia
  23. Biochemical reference intervals for sex hormones with a new AutoDelfia method in aged men
  24. The Italian External Quality Control Programme for cystic fibrosis molecular diagnosis: 4 years of activity
  25. Standardization of ischemia-modified albumin testing: adjustment for serum albumin
  26. Is simultaneous measurement of anti-thyroid peroxidase and anti-thyroglobulin antibodies clinically useful in patients with thyroid dysfunction?
  27. To the Editor: In reply to Nakano et al. Clin Chem Lab Med 2006;44(5):522–532
  28. To the Editor: Author reply; Nakano et al. Clin Chem Lab Med 2006;44(5):522–532
  29. Accreditation of medical laboratories in the European Union
  30. Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge
Heruntergeladen am 30.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.028/html?lang=de
Button zum nach oben scrollen